Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
SMARTSCORE: 3.6/5
SanBio Co Ltd (4592 JP)
Watchlist
35
Analysis
Health Care
•
Japan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
10 Mar 2019 09:31
🇯🇵 Japan: Moving Average Outliers - AnGes, SanBio, Adastria, AIN, Sumco & Benefit One
- MARKET COMPOSITE - SOUTHBOUND - The upside we anticipated two weeks ago turned out to be only ¥6t before the harsh realities of some weak macro...
Campbell Gunn
Follow
275 Views
Share
bullish
•
Quantitative Analysis
•
24 Feb 2019 07:43
🇯🇵 Japan: Moving Average Outliers - PKSHA, SanBio, Goldwin, ZOZO, Drugstores & ASICS
- MARKET COMPOSITE -ALMOST THREE-MONTH HIGH RECOVERY - The bear market rally is now in its second stage, and the market composite is now 14% above...
Campbell Gunn
Follow
573 Views
Share
bullish
•
Quantitative Analysis
•
10 Feb 2019 10:46
Japan: Moving Average Outliers - Lasertec, SanBio, Digital Arts, Modec & Leopalace21
- MARKET COMPOSITE -RECOVERY TOPPING OUT - Both the market and our 'percentage-above-moving-averages' ratio peaked on 5th February and, as covered...
Campbell Gunn
Follow
427 Views
Share
bullish
•
CyberAgent Inc
•
10 Feb 2019 00:10
CyberAgent: Tumbling Dice
TUMBLING DICE - After ZOZO (3092 JP) (-52%) and Mercari (4385 JP) (-50%), CyberAgent (4751 JP) is the worst-performing large-cap Internet stock in...
Campbell Gunn
Follow
731 Views
Share
bearish
•
Quantitative Analysis
•
03 Feb 2019 10:32
Japan Fortnightly Update: Drip, Drip, Drip...
DRIP, DRIP, DRIP - We 'lead' this fortnight's update with our All-Market Composite Results & Revision Score. Calculated daily, the score is a...
Campbell Gunn
Follow
445 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x